腹内感染外科危重病人多重耐药菌的抗生素处方模式和危险因素。

IF 1.4 4区 医学 Q4 INFECTIOUS DISEASES
Tara S Ladsavong, Benjamin R Brewer, Kelli A Rumbaugh
{"title":"腹内感染外科危重病人多重耐药菌的抗生素处方模式和危险因素。","authors":"Tara S Ladsavong, Benjamin R Brewer, Kelli A Rumbaugh","doi":"10.1177/10962964251383707","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background:</i></b> Guidelines for the treatment of intra-abdominal infections (IAIs) recommend a variety of potential antimicrobial regimens; however, there is a lack of real-world data documenting prescribing practices and incidence of multidrug-resistant organisms (MDROs). <b><i>Methods:</i></b> A single-center, retrospective study from June 1, 2021 to April 30, 2023, was conducted to evaluate patients with an IAI admitted to the surgical intensive care unit. Patients were categorized into four groups based on the primary gram-negative antibiotic initially prescribed for IAI treatment: piperacillin-tazobactam, cefepime, levofloxacin, and meropenem. The primary outcome was antibiotic prescribing practices for IAI. Regression analyses were conducted to evaluate risk factors for MDRO, duration of antibiotics, and mortality. <b><i>Results:</i></b> A total of 334 patients were included. Most patients received piperacillin-tazobactam (n = 227, 68%), followed by cefepime (n = 122, 36.5%), meropenem (n = 73, 21.9%), and levofloxacin (n = 61, 18.3%). There were 301 patients prescribed vancomycin for a median of 4 days (interquartile range [IQR]: 3-7). The median antibiotic duration was 8 days (IQR: 5-12). Variables associated with prolonged antibiotics were infectious disease consult (p < 0.001), multiple intra-abdominal procedures (p = 0.006), and exposure to more than one gram-negative antibiotic (p = 0.004). Predictors of MDRO were longer durations of antibiotics (odds ratio [OR]: 1.04, 95% confidence interval [CI]: 1.01-1.07) and meropenem exposure (OR: 2.11, 95% CI: 1.12-3.98). Older age (OR: 1.05, 95% CI: 1-1.08, p = 0.007) and septic shock (OR: 2.8, 95% CI: 1.3-6.1, p = 0.003) were risk factors for mortality. <b><i>Conclusions:</i></b> Piperacillin-tazobactam was the most frequently prescribed antibiotic for treatment of IAI in critically ill surgical patients. Prolonged durations of broad-spectrum antibiotics should be avoided due to the risk of developing an MDRO infection.</p>","PeriodicalId":22109,"journal":{"name":"Surgical infections","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Antibiotic Prescribing Patterns and Risk Factors for Multidrug-Resistant Organisms in Critically Ill Surgical Patients with Intra-Abdominal Infections.\",\"authors\":\"Tara S Ladsavong, Benjamin R Brewer, Kelli A Rumbaugh\",\"doi\":\"10.1177/10962964251383707\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background:</i></b> Guidelines for the treatment of intra-abdominal infections (IAIs) recommend a variety of potential antimicrobial regimens; however, there is a lack of real-world data documenting prescribing practices and incidence of multidrug-resistant organisms (MDROs). <b><i>Methods:</i></b> A single-center, retrospective study from June 1, 2021 to April 30, 2023, was conducted to evaluate patients with an IAI admitted to the surgical intensive care unit. Patients were categorized into four groups based on the primary gram-negative antibiotic initially prescribed for IAI treatment: piperacillin-tazobactam, cefepime, levofloxacin, and meropenem. The primary outcome was antibiotic prescribing practices for IAI. Regression analyses were conducted to evaluate risk factors for MDRO, duration of antibiotics, and mortality. <b><i>Results:</i></b> A total of 334 patients were included. Most patients received piperacillin-tazobactam (n = 227, 68%), followed by cefepime (n = 122, 36.5%), meropenem (n = 73, 21.9%), and levofloxacin (n = 61, 18.3%). There were 301 patients prescribed vancomycin for a median of 4 days (interquartile range [IQR]: 3-7). The median antibiotic duration was 8 days (IQR: 5-12). Variables associated with prolonged antibiotics were infectious disease consult (p < 0.001), multiple intra-abdominal procedures (p = 0.006), and exposure to more than one gram-negative antibiotic (p = 0.004). Predictors of MDRO were longer durations of antibiotics (odds ratio [OR]: 1.04, 95% confidence interval [CI]: 1.01-1.07) and meropenem exposure (OR: 2.11, 95% CI: 1.12-3.98). Older age (OR: 1.05, 95% CI: 1-1.08, p = 0.007) and septic shock (OR: 2.8, 95% CI: 1.3-6.1, p = 0.003) were risk factors for mortality. <b><i>Conclusions:</i></b> Piperacillin-tazobactam was the most frequently prescribed antibiotic for treatment of IAI in critically ill surgical patients. Prolonged durations of broad-spectrum antibiotics should be avoided due to the risk of developing an MDRO infection.</p>\",\"PeriodicalId\":22109,\"journal\":{\"name\":\"Surgical infections\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-10-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Surgical infections\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/10962964251383707\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Surgical infections","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/10962964251383707","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

摘要

背景:腹内感染(IAIs)治疗指南推荐了多种潜在的抗菌方案;然而,缺乏记录处方做法和耐多药微生物(mdro)发生率的真实数据。方法:在2021年6月1日至2023年4月30日期间进行了一项单中心回顾性研究,以评估入住外科重症监护病房的IAI患者。根据最初用于IAI治疗的主要革兰氏阴性抗生素将患者分为四组:哌拉西林-他唑巴坦、头孢吡肟、左氧氟沙星和美罗培南。主要结果是IAI的抗生素处方实践。进行回归分析以评估MDRO的危险因素、抗生素持续时间和死亡率。结果:共纳入334例患者。服用哌拉西林-他唑巴坦最多(n = 227,占68%),其次是头孢吡肟(n = 122,占36.5%)、美罗培南(n = 73,占21.9%)、左氧氟沙星(n = 61,占18.3%)。301例患者服用万古霉素的中位时间为4天(四分位数间距[IQR]: 3-7)。抗生素持续时间中位数为8天(IQR: 5-12)。与长期使用抗生素相关的变量是传染病咨询(p < 0.001)、多次腹腔内手术(p = 0.006)和接触一种以上革兰氏阴性抗生素(p = 0.004)。MDRO的预测因子是抗生素持续时间较长(优势比[OR]: 1.04, 95%可信区间[CI]: 1.01-1.07)和美罗培南暴露(OR: 2.11, 95% CI: 1.12-3.98)。高龄(OR: 1.05, 95% CI: 1 ~ 1.08, p = 0.007)和感染性休克(OR: 2.8, 95% CI: 1.3 ~ 6.1, p = 0.003)是死亡的危险因素。结论:哌拉西林-他唑巴坦是外科危重患者治疗IAI最常用的抗生素。由于有发生MDRO感染的风险,应避免长时间使用广谱抗生素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Antibiotic Prescribing Patterns and Risk Factors for Multidrug-Resistant Organisms in Critically Ill Surgical Patients with Intra-Abdominal Infections.

Background: Guidelines for the treatment of intra-abdominal infections (IAIs) recommend a variety of potential antimicrobial regimens; however, there is a lack of real-world data documenting prescribing practices and incidence of multidrug-resistant organisms (MDROs). Methods: A single-center, retrospective study from June 1, 2021 to April 30, 2023, was conducted to evaluate patients with an IAI admitted to the surgical intensive care unit. Patients were categorized into four groups based on the primary gram-negative antibiotic initially prescribed for IAI treatment: piperacillin-tazobactam, cefepime, levofloxacin, and meropenem. The primary outcome was antibiotic prescribing practices for IAI. Regression analyses were conducted to evaluate risk factors for MDRO, duration of antibiotics, and mortality. Results: A total of 334 patients were included. Most patients received piperacillin-tazobactam (n = 227, 68%), followed by cefepime (n = 122, 36.5%), meropenem (n = 73, 21.9%), and levofloxacin (n = 61, 18.3%). There were 301 patients prescribed vancomycin for a median of 4 days (interquartile range [IQR]: 3-7). The median antibiotic duration was 8 days (IQR: 5-12). Variables associated with prolonged antibiotics were infectious disease consult (p < 0.001), multiple intra-abdominal procedures (p = 0.006), and exposure to more than one gram-negative antibiotic (p = 0.004). Predictors of MDRO were longer durations of antibiotics (odds ratio [OR]: 1.04, 95% confidence interval [CI]: 1.01-1.07) and meropenem exposure (OR: 2.11, 95% CI: 1.12-3.98). Older age (OR: 1.05, 95% CI: 1-1.08, p = 0.007) and septic shock (OR: 2.8, 95% CI: 1.3-6.1, p = 0.003) were risk factors for mortality. Conclusions: Piperacillin-tazobactam was the most frequently prescribed antibiotic for treatment of IAI in critically ill surgical patients. Prolonged durations of broad-spectrum antibiotics should be avoided due to the risk of developing an MDRO infection.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Surgical infections
Surgical infections INFECTIOUS DISEASES-SURGERY
CiteScore
3.80
自引率
5.00%
发文量
127
审稿时长
6-12 weeks
期刊介绍: Surgical Infections provides comprehensive and authoritative information on the biology, prevention, and management of post-operative infections. Original articles cover the latest advancements, new therapeutic management strategies, and translational research that is being applied to improve clinical outcomes and successfully treat post-operative infections. Surgical Infections coverage includes: -Peritonitis and intra-abdominal infections- Surgical site infections- Pneumonia and other nosocomial infections- Cellular and humoral immunity- Biology of the host response- Organ dysfunction syndromes- Antibiotic use- Resistant and opportunistic pathogens- Epidemiology and prevention- The operating room environment- Diagnostic studies
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信